The evaluation of kidney biopsies performed by expert pathologists is a crucial process for assessing if a kidney is eligible for transplantation. In this evaluation process, an important step consists of the quantification of global glomerulosclerosis, which is the ratio between sclerotic glomeruli and the overall number of glomeruli. Since there is a shortage of organs available for transplantation, a quick and accurate assessment of global glomerulosclerosis is essential for retaining the largest number of eligible kidneys. In the present paper, the authors introduce a Computer-Aided Diagnosis (CAD) system to assess global glomerulosclerosis. The proposed tool is based on Convolutional Neural Networks (CNNs). In particular, the authors considered approaches based on Semantic Segmentation networks, such as SegNet and DeepLab v3+. The dataset has been provided by the Department of Emergency and Organ Transplantations (DETO) of Bari University Hospital, and it is composed of 26 kidney biopsies coming from 19 donors. The dataset contains 2344 non-sclerotic glomeruli and 428 sclerotic glomeruli. The proposed model consents to achieve promising results in the task of automatically detecting and classifying glomeruli, thus easing the burden of pathologists. We get high performance both at pixel-level, achieving mean F-score higher than 0.81, and Weighted Intersection over Union (IoU) higher than 0.97 for both SegNet and Deeplab v3+ approaches, and at object detection level, achieving 0.924 as best F-score for non-sclerotic glomeruli and 0.730 as best F-score for sclerotic glomeruli.
The histological assessment of glomeruli is fundamental for determining if a kidney is suitable for transplantation. The Karpinski score is essential to evaluate the need for a single or dual kidney transplant and includes the ratio between the number of sclerotic glomeruli and the overall number of glomeruli in a kidney section. The manual evaluation of kidney biopsies performed by pathologists is time-consuming and error-prone, so an automatic framework to delineate all the glomeruli present in a kidney section can be very useful. Our experiments have been conducted on a dataset provided by the Department of Emergency and Organ Transplantations (DETO) of Bari University Hospital. This dataset is composed of 26 kidney biopsies coming from 19 donors. The rise of Convolutional Neural Networks (CNNs) has led to a realm of methods which are widely applied in Medical Imaging. Deep learning techniques are also very promising for the segmentation of glomeruli, with a variety of existing approaches. Many methods only focus on semantic segmentation—which consists in segmentation of individual pixels—or ignore the problem of discriminating between non-sclerotic and sclerotic glomeruli, so these approaches are not optimal or inadequate for transplantation assessment. In this work, we employed an end-to-end fully automatic approach based on Mask R-CNN for instance segmentation and classification of glomeruli. We also compared the results obtained with a baseline based on Faster R-CNN, which only allows detection at bounding boxes level. With respect to the existing literature, we improved the Mask R-CNN approach in sliding window contexts, by employing a variant of the Non-Maximum Suppression (NMS) algorithm, which we called Non-Maximum-Area Suppression (NMAS). The obtained results are very promising, leading to improvements over existing literature. The baseline Faster R-CNN-based approach obtained an F-Measure of 0.904 and 0.667 for non-sclerotic and sclerotic glomeruli, respectively. The Mask R-CNN approach has a significant improvement over the baseline, obtaining an F-Measure of 0.925 and 0.777 for non-sclerotic and sclerotic glomeruli, respectively. The proposed method is very promising for the instance segmentation and classification of glomeruli, and allows to make a robust evaluation of global glomerulosclerosis. We also compared Karpinski score obtained with our algorithm to that obtained with pathologists’ annotations to show the soundness of the proposed workflow from a clinical point of view.
The COVID-19 pandemic is inevitably changing the world in a dramatic way, and the role of computed tomography (CT) scans can be pivotal for the prognosis of COVID-19 patients. Since the start of the pandemic, great care has been given to the relationship between interstitial pneumonia caused by the infection and the onset of thromboembolic phenomena. In this preliminary study, we collected n = 20 CT scans from the Polyclinic of Bari, all from patients positive with COVID-19, nine of which developed pulmonary thromboembolism (PTE). For eight CT scans, we obtained masks of the lesions caused by the infection, annotated by expert radiologists; whereas for the other four CT scans, we obtained masks of the lungs (including both healthy parenchyma and lesions). We developed a deep learning-based segmentation model that utilizes convolutional neural networks (CNNs) in order to accurately segment the lung and lesions. By considering the images from publicly available datasets, we also realized a training set composed of 32 CT scans and a validation set of 10 CT scans. The results obtained from the segmentation task are promising, allowing to reach a Dice coefficient higher than 97%, posing the basis for analysis concerning the assessment of PTE onset. We characterized the segmented region in order to individuate radiomic features that can be useful for the prognosis of PTE. Out of 919 extracted radiomic features, we found that 109 present different distributions according to the Mann–Whitney U test with corrected p-values less than 0.01. Lastly, nine uncorrelated features were retained that can be exploited to realize a prognostic signature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.